Approval reinforces Myriad’s leadership in comprehensive HRD testing and establishes MyChoice CDx as the only FDA-approved ...

Myriad Genetics received approval for a diagnostic test aimed at identifying advanced ovarian cancer patients eligible for treatment with Zejula from the Food and Drug Administration.

Myriad Genetics receives US FDA approval for MyChoice CDx test as companion diagnostic for Zejula for patients with ovarian cancer: Salt Lake City Thursday, March 19, 2026, 15:00 ...

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that the U.S. Food and Drug ...

Discover the groundbreaking Elecsys® AMH Plus blood test by Redcliffe Labs and Roche Diagnostics India that offers an easier, less invasive way to diagnose Polycystic Ovary Syndrome (PCOS), ensuring ...

An ovarian cancer survivor reflects on community, advocacy, and living a life shaped by purpose—not just diagnosis.

Redcliffe Labs has launched the Elecsys AMH Plus blood test in collaboration with Roche Diagnostics India to support identification of Polycystic Ovarian Morphology (PCOM) and aid in the diagnosis of ...

A discovery from Mayo Clinic researchers in Rochester shows a certain lung cancer treatment can also be used to treat aggressive cases of ovarian cancer. The study published by clinic researchers in ...

Dr. Sheeva Talebian is haunted by how long “we’ve conditioned women to believe that debilitating pain is normal.” It’s a “clinical failure,” she declared, and it’s a reason why symptoms of one tricky ...

A new study found that women who went through so-called premature menopause had 40 percent more fatal and nonfatal heart ...

BRCA gene mutations can significantly raise a woman’s risk of breast and ovarian cancer. Know how hereditary cancer risk works and why genetic testing and early screening matter.

ASX-listed healthcare companies are increasingly teaming up with universities to fast-track new therapies, combining academic research with clinical and commercial ... Read More The post ASX ...